Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries and one of its wholly-owned subsidiaries (collectively Sun Pharma) have entered into settlements with certain plaintiffs in re Modafinil Antitrust Litigation matter currently pending in the United States District Court for the Eastern District of Pennsylvania.

The settlements extend to all claims brought by Apotex Corporation and the Retailer Purchaser Plaintiffs. The settlements remain subject to the execution of definitive documentation and the terms of the settlement are confidential.

Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.